Navigation Links
Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
Date:1/3/2008

KENILWORTH, N.J., Jan. 2 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced that the U.S. Food and Drug Administration (FDA) has assigned priority review status to the company's New Drug Application (NDA) for sugammadex.

Sugammadex is specifically designed to reverse the effects of certain muscle relaxants, marketed in the United States as ZEMURON(R) (rocuronium bromide) and vecuronium bromide. Muscle relaxants are used as part of general anesthesia during surgical procedures. If approved, sugammadex will be the first in a new class of drugs known as selective relaxant binding agents that work in an entirely new and unique way to encapsulate the muscle relaxant molecule and render it inactive.

"Organon, now part of Schering-Plough Corporation, has had a strong presence in the anesthesia market for over 35 years," said Robert J. Spiegel, M.D., chief medical officer and senior vice president, Schering-Plough Research Institute. "The development of sugammadex is an exciting advance for the practice of anesthesia. This novel drug has the potential to change the way doctors practice anesthesia as it will allow anesthesiologists to rapidly and safely reverse both shallow and profound levels of muscle relaxation, which is not possible with current reversal agents."

Schering-Plough acquired sugammadex through its combination with Organon BioSciences on November 19, 2007.

About Sugammadex

Sugammadex is a novel selective relaxant binding agent (SRBA) under development by Organon, a part of Schering-Plough Corporation. Sugammadex was designed to reverse the effects of rocuronium bromide (ZEMURON/ESMERON(R)/ESLAX(R)) or vecuronium bromide, muscle relaxants commonly used during surgeries
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
2. Schering-Plough Announces Pricing of Senior Notes Offering
3. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
4. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
5. Schering-Plough Completes Acquisition of Organon BioSciences
6. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
7. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
8. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
11. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... San Diego, CA (PRWEB) January 14, 2014 ... based on the products of cells grown under simulated ... an international license agreement with Suneva Medical, Inc. for ... media (CCM). , This agreement is an ...
(Date:1/14/2014)... 2014 As pet owners drew up their lists of New ... "Take better care of my furry companion." Nowadays there are pet ... carrying cases to take the little canine or feline darlings along ... to buy some pricey toys at the pet store. But anyone ...
(Date:1/14/2014)... Texas , Jan. 14, 2014 The ... and research medicinal plants and therapeutic derivatives thereof ... health professionals, and researchers about the challenges of ... http://photos.prnewswire.com/prnh/20100430/DC95601LOGO ) The Society ...
(Date:1/14/2014)... iLab Solutions, the leader in core facility management software, ... Strategy. In this role, Michelle will work with current and ... the development of iLab products. Her main goal will be ... the scientific community by offering the most advanced, user-friendly, and ...
Breaking Biology Technology:Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 4World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 5World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 6World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 7World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 8iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2
... Rapid Purification of Endotoxin-Free Plasmid DNA , ... HP Endotoxin-Free Plasmid Maxiprep,Kit offers a novel ... A patent-pending,endotoxin removal process has resulted in ... endotoxin-free DNA (≤ 0.1 EU/g).,This product delivers ...
... ,I. Description ,II. Product Components ,III. ... Protocol for Extraction of DNA from Soil ,V. ... ,VI. Quantification of Amplified products ,VII. Purification ... Contact Information , , , ,Application Guide, , I. ...
... ,I. Description ,II. Product Components ,III. ... Protocol for Extraction of DNA from Buccal Swab ... Swab ,VI. Quantification of Amplified Products ,VII. ... Application Data , References , Contact Information ...
Cached Biology Technology:Introducing,GenElute HP,Endotoxin-Free Plasmid,Maxiprep Kit 2Introducing,GenElute HP,Endotoxin-Free Plasmid,Maxiprep Kit 3Introducing,GenElute HP,Endotoxin-Free Plasmid,Maxiprep Kit 4Introducing,GenElute HP,Endotoxin-Free Plasmid,Maxiprep Kit 5Protocol for GenomePlex Whole Genome Amplification from Soil 2Protocol for GenomePlex Whole Genome Amplification from Soil 3Protocol for GenomePlex Whole Genome Amplification from Soil 4Protocol for GenomePlex Whole Genome Amplification from Soil 5Protocol for GenomePlex Whole Genome Amplification ,from Buccal Swab 2Protocol for GenomePlex Whole Genome Amplification ,from Buccal Swab 3Protocol for GenomePlex Whole Genome Amplification ,from Buccal Swab 4Protocol for GenomePlex Whole Genome Amplification ,from Buccal Swab 5Protocol for GenomePlex Whole Genome Amplification ,from Buccal Swab 6
(Date:4/24/2014)... led by Alison Allan, PhD, a scientist at Western ... breast cancer often spreads or metastasizes to the lung. ... and the number two cause of cancer-related deaths among ... chemotherapy and radiation have a high success rate, but ... treatments fail. In particular, the lung is one of ...
(Date:4/24/2014)... a simple and cheap way of making a high-powered ... high-resolution microscope. , Costing less than a cent, the ... developing countries and remote areas. , The lens fabrication ... Australian National University (ANU) Research School of Engineering, who ... of Medical Research to find ways to transform the ...
(Date:4/24/2014)... Munich have identified the structural features that enable ... and endogenous RNAs in living cells. , When ... metabolism and hijack cellular resources for the production ... viral RNA molecules that are delivered directly to ... synthesized in the host cell, and provide the ...
Breaking Biology News(10 mins):New study helps to explain why breast cancer often spreads to the lung 2Droplet lens 2Viral infections: Identifying the tell-tale patterns 2Viral infections: Identifying the tell-tale patterns 3
... gene for schizophrenia and exposed to lead during early ... consistent with schizophrenia. Scientists at Columbia University,s Mailman School ... of Medicine say their findings suggest a synergistic effect ... open an avenue to better understanding the complex gene-environment ...
... When language switching has no apparent ... the remarkable ability to switch from one language to the ... Pennsylvania State University, USA, looked at whether language switching incurs ... little difficulty in preventing such mix-ups between languages. When 26 ...
... is a well-known recreational drug, extensive scientific research has ... the last decade. Medical cannabis is often used by ... disorder, to combat pain, insomnia, lack of appetite, and ... Aviv University,s Adelson Center for the Biology of Addictive ...
Cached Biology News:Lead acts to trigger schizophrenia 2Frontiers news briefs May 30 2Frontiers news briefs May 30 3Frontiers news briefs May 30 4Low doses of THC can halt brain damage 2Low doses of THC can halt brain damage 3
...
... have moderate chemiluminescence efficiencies and the chemistry ... have the added benefit that they require ... the background signal. This benefit has been ... immunoassay applications. These compounds can also be ...
ssDNA from PCR DNA in less than 1 hour. No gels, columns, or slurries. Sequence from high quality ssDNA: clearer reads, longer runs....
Applications: Immunohistochemistry, ISH, FISH, CISH....
Biology Products: